| Title |
Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study
|
|---|---|
| Published in |
BMC Pulmonary Medicine, November 2014
|
| DOI | 10.1186/1471-2466-14-178 |
| Pubmed ID | |
| Authors |
Dave Singh, Paul W Jones, Eric D Bateman, Stephanie Korn, Cristina Serra, Eduard Molins, Cynthia Caracta, Esther Garcia Gil, Anne Leselbaum |
| Abstract |
Aclidinium/formoterol is a twice-daily (BID) fixed-dose combination (FDC) in development for chronic obstructive pulmonary disease (COPD). The efficacy and safety of aclidinium/formoterol versus monotherapy and placebo in patients with COPD was assessed. |
Mendeley readers
The data shown below were compiled from readership statistics for 107 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 2% |
| Sweden | 1 | <1% |
| Unknown | 104 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 17 | 16% |
| Student > Master | 16 | 15% |
| Other | 15 | 14% |
| Student > Bachelor | 10 | 9% |
| Student > Postgraduate | 7 | 7% |
| Other | 21 | 20% |
| Unknown | 21 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 45 | 42% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 7% |
| Nursing and Health Professions | 7 | 7% |
| Agricultural and Biological Sciences | 5 | 5% |
| Economics, Econometrics and Finance | 3 | 3% |
| Other | 15 | 14% |
| Unknown | 24 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 May 2018.
All research outputs
#1,804,390
of 22,950,943 outputs
Outputs from BMC Pulmonary Medicine
#83
of 1,941 outputs
Outputs of similar age
#26,577
of 363,625 outputs
Outputs of similar age from BMC Pulmonary Medicine
#5
of 40 outputs
Altmetric has tracked 22,950,943 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,941 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 363,625 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 40 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.